Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study

摘要

BackgroundAlthough pharmacotherapy is one of the most important treatments for schizophrenia, the prominent levels of antipsychotic polypharmacy and high-dose regimens used in Japan are thought to be inconsistent with treatment regimens used in other countries. In this study, we evaluated the effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia.